Ocular surface microbiome in diabetes mellitus
- Conditions
- Type 2 Diabetes mellitusOcular surface microbiomeConjunctival microbiomeHuman microbiomeDiabetes mellitusDMDiabetes retinopathyDRNext generation sequencingNGS
- Registration Number
- TCTR20210427010
- Lead Sponsor
- Ratchadapisek Sompoch fund
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- All
- Target Recruitment
- 80
1. Subjects aged over 18 years old
2. In diabetes group: subjects who have diagnosed with type 2 diabetes mellitus according to the ADA (American Diabetes Association) diagnostic criteria or the subjects with a known history of diabetes mellitus which the patients were under the care of physicians
3. In control group: subjects who have no diabetes mellitus and history of normal blood sugar or HbA1c screening for diabetes within 1 year.
1. Ocular surface diseases (ex. significant dry eye, Meibomian gland dysfunction,
Stevens-Johnson syndrome)
2. History of ocular and periocular infection/inflammation, allergic conjunctivitis
within 3 months
3. History of Previous contact lens used within 3 months
4. History ocular medication used (except for non-preservative artificial tear) within 1 month
(such as topical antibiotic, topical steroid, intravitreal drug injection etc.)
5. History of ocular surgery within past 3 months
6. History of systemic antibiotic, steroid or immunosuppressive drug used within past 3 months
7. Health care workers
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ocular surface microbiome in diabetes mellitus patients, compared with control at the time of specimen collection Bioinformatic data : relative abundance, alpha/beta diversity
- Secondary Outcome Measures
Name Time Method Ocular surface microbiome in the different stage of diabetes retinopathy at the time of specimen collection Bioinformatic data : relative abundance, alpha/beta diversity,Ocular surface microbiome in diabetes mellitus according to HbA1C level at the time of specimen collection Bioinformatic data : relative abundance, alpha/beta diversity,Culture positive and antibiotic resistance at the time of specimen collection Percentage of culture positive and antibiotic resistance